Proroxan

Polymerase I and transcript release factor (PTRF) contains a leucine zipper motif, a nuclear localization signal, and PEST domains. It is critically involved in termination of transcription by stalling RNA poly I and releasing it from the

Immunogen 17 amino amino terminus of human Apaf1. Application Used as a blocking peptide in immunoblotting applications.

Immunogen 14 amino acids near the carboxy terminus of human CARD10 Application Used as a blocking peptide in immunoblotting applications. Linkage This peptide blocks the action of antibody PRS3013 .

Immunogen 15 amino acids near the carboxy terminus of human CSN8. Application Used as a blocking peptide in immunoblotting applications.

Immunogen 14 amino acids near the center of human GFR alpha 1. Application Used as a blocking peptide in immunoblotting applications.

Immunogen 15 amino acids near the center of human GFR-2. Application Used as a blocking peptide in immunoblotting applications.

Immunogen 14 amino acids near the center of human GFR alpha 3. Application Used as a blocking peptide in immunoblotting applications.

Immunogen 16 amino acids near the amino terminus of human IL-27. Application Used as a blocking peptide in immunoblotting applications.

Immunogen 14 amino acids near the center of human IL-27. Application Used as a blocking peptide in immunoblotting applications.

Pharmacological agent that reportedly may show activity through ability to inhibit prostaglandin biosynthesis. Non-selective cyclooxygenase (COX-1 and COX-2) inhibitor.

Pharmacological agent that reportedly may show activity through ability to inhibit prostaglandin biosynthesis. Non-selective cyclooxygenase (COX-1 and COX-2) inhibitor.

Pharmacological agent that reportedly may show activity through ability to inhibit prostaglandin biosynthesis. Non-selective cyclooxygenase (COX-1 and COX-2) inhibitor.